SPARC and neoplasm: To test whether Sparc−/− MDSC have defective NF-kB activation, we evaluated p65 and p50 translocation into the nucleus of BM-differentiated MDSC (28) from WT and Sparc−/− mice, after exposure to tumor supernatants or, as control, to LPS.